Physician profile
Christopher K Tidwell
NPI 1114032323
$6,253.67
in general payments reported to CMS, 2019-2025
38 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,025 · 2020: $723 · 2021: $1,322 · 2022: $1,207 · 2023: $827 · 2024: $1,151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,978.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,977.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $2,053.01 | 2019-2024 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $954.29 | 2019-2024 | Tezspire, Breztri, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $602.60 | 2019-2024 | Ofev |
| Regeneron Healthcare Solutions, INC. | $490.72 | 2019-2024 | Dupixent |
| Insmed, INC. | $443.55 | 2019-2024 | Arikayce |
| Genzyme Corporation | $250.75 | 2022-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $183.46 | 2020-2024 | Glassia |
| Inspire Medical Systems, INC. | $139.15 | 2024 | Inspire |
| Inogen, INC. | $133.50 | 2022-2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Mylan Specialty L.P. | $126.90 | 2019-2024 | Yupelri |
| United Therapeutics Corporation | $104.04 | 2021 | |
| Circassia INC. | $101.30 | 2019-2020 | |
| Grifols USA, LLC | $63.56 | 2022 | |
| Merck Sharp & Dohme LLC | $61.93 | 2022-2023 | |
| Mallinckrodt Hospital Products INC. | $60.31 | 2022-2023 | Acthar |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Advanced Respiratory, INC | $42.61 | 2020-2021 | |
| Shire North American Group INC | $37.26 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $34.41 | 2020-2021 | |
| Therapeuticsmd, INC. | $33.79 | 2020 | |
| Amgen INC. | $31.39 | 2022-2024 | Tezspire |
| Pfizer INC. | $29.74 | 2021-2023 | |
| Teva Pharmaceuticals USA, INC. | $26.74 | 2021-2022 | |
| Baxter Healthcare | $24.15 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Horizon Therapeutics Plc | $23.09 | 2020 | |
| Olympus America INC. | $19.21 | 2021 | |
| Adma Biomanufacturing LLC | $17.92 | 2021 | |
| La Jolla Pharmaceutical Company | $16.34 | 2023 | Giapreza |
| Ambu INC. | $15.56 | 2024 | |
| Electromed, INC. | $14.53 | 2021 | |
| Gilead Sciences, INC. | $14.13 | 2019 | |
| Allergan, INC. | $13.82 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.67 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $13.66 | 2021 | |
| Paratek Pharmaceuticals, INC. | $13.61 | 2023 | Nuzyra |
| Boston Scientific Corporation | $12.91 | 2019 | |
| Mallinckrodt Enterprises LLC | $12.09 | 2019 | |
| Genentech USA, INC. | $12.07 | 2021 | |
| Avion Pharmaceuticals | $11.90 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Tidwell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.